Prime Highlights-
- India marked a strong presence at the 50th Arab Health Exhibition and Congress in Dubai with 361 companies participating across pharmaceuticals, medical devices, and healthcare solutions.
- The event offers Indian healthcare and pharma companies an opportunity to expand exports and strengthen their presence in the growing Middle East healthcare market.
Key Facts-
- Of the 361 Indian exhibitors, 65 companies are participating under the Pharmexcil Pavilion, while 22 medical device manufacturers are showcasing products through the EEPC Pavilion.
- The global healthcare market is projected to reach US$780 billion by 2030, while the consumer healthcare segment is expected to grow at an annual rate of 8%through 2030.
Background-
The 50th Arab Health Exhibition and Congress opened at the Dubai World Trade Centre with 361 Indian companies among its participants, making India one of the more prominent national contingents at this year’s event.
The four-day exhibition, which runs through January 30, brings together pharmaceutical manufacturers, medical device makers, and healthcare solution providers from across the world.
India’s participation is backed by the Ministry of Commerce and Industry, with coordination handled by the Pharmaceuticals Export Promotion Council of India, known as Pharmexcil.
Of the 361 Indian firms present, 65 are exhibiting under the Pharmexcil Pavilion and 22 medical device manufacturers are displaying their products at the EEPC Pavilion.
Companies including HLL Lifecare Ltd., Bharat Parenterals Ltd. and Zuvius Lifesciences Pvt. Ltd. are showcasing pharmaceutical formulations, nutraceuticals, oncology products, and active pharmaceutical ingredients at their respective stalls. remove ai
The timing works in India’s favor. Industry analysts project the global healthcare market will touch US$780 billion by 2030, while the consumer healthcare segment alone, valued at US$360 billion in 2023, is expected to grow at 8.8 percent annually through the same period. For Indian exporters, the Middle East represents a growing and accessible market.
This edition of Arab Health has drawn participation from over 40 country pavilions, including first-time exhibitors Morocco and Latvia, marking what organizers describe as record international attendance for the exhibition.
For India’s pharmaceutical sector, the event is less about visibility and more about deal-making. The country has steadily built a reputation as a supplier of affordable, quality-certified medicines and medical devices and exhibitions like this one serve as the primary channel for converting that reputation into export contracts.
